Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
CD40LG (CD40 ligand) encodes a type‑II transmembrane TNF‑superfamily glycoprotein localizing predominantly to plasma‑membrane compartments of activated immune‑lineage cells; proteolytic processing also generates detectable soluble protein pools within extracellular spacesPMC. This protein is detectable across multiple activated immune cell populations and exhibits stimulus‑dependent, non‑uniform tissue‑level distribution patterns. Distinct from purely soluble intracellular factors, it contains a short cytosolic N‑terminal segment, single transmembrane helix and large extracellular C‑terminal domain and lacks independent catalytic functional modules. It acts as a membrane‑resident trimer‑prone ligand subunit, cooperating with adjacent plasma‑membrane‑embedded protein components to shape immune‑cell‑surface‑associated molecular arrangements under physiological conditions. Insufficient adequate CD40LG protein abundance could disturb normal surface receptor‑ligand complex assembly and interfere with downstream immune‑cell membrane adaptive properties. CD40LG may provide molecular buffering to sustain appropriate receptor‑ligand‑dependent molecular arrangement across immune cell populations. Distinct cellular activation and differentiation stages bring varied immune costimulation demands, requiring diversified membrane‑embedded ligand glycoproteins to support multicellular tissue physiological equilibrium. Membrane‑localized CD40LG assembles with partner membrane protein units to counteract aberrant surface‑complex arrangement shifts and help sustain stable plasma‑membrane functional characteristics.
Sequence‑level alterations to the CD40LG locus may compromise the structural organisation of assembled plasma‑membrane receptor‑ligand complexes and alter readouts derived from cell‑surface molecular interaction events. Closely related members of the TNF ligand superfamily cannot fully replicate the complete set of CD40LG‑dependent behaviours during heteromeric surface‑complex formation and stable integration within plasma‑membrane assemblies. Shifts in CD40LG protein levels often align with cellular demands for immune‑costimulation‑related activities, making this protein a useful research target to explore TNF‑ligand‑family activities and immune‑cell‑surface molecular dynamics. Found primarily on activated‑cell plasma membranes alongside processed soluble fractions, CD40LG contributes to heteromeric surface‑complex formation and does not maintain constitutive persistent downstream signalling activity within its own host cell. Its multi‑domain type‑II transmembrane architecture built for trimer assembly distinguishes this glycoprotein from many other immune‑associated surface proteins; such structural features support the maintenance of immune‑surface‑complex arrangement and permit selective physical contacts with cell‑surface binding partners. Diminished functional performance of CD40LG may disturb the proper arrangement of immune‑cell surface assemblies and weaken endogenous cellular adaptive buffering capacity, further supporting its research value for studies focused on TNF‑superfamily membrane‑ligand components.
Fig. 1 Topology schematic of type-II TNF-superfamily membrane ligand CD40LG. It features short intracellular N-terminus, single transmembrane helix and extracellular C-terminal THD domain, which may support trimer-prone surface complex assembly under physiological conditions.1
The biological functions of transmembrane CD40LG glycoprotein are focused on sustained heteromeric partner-complex interaction and plasma-membrane-homeostasis coordination:
Creative Biolabs offers purified CD40LG membrane samples produced under unified preparation workflows, including full-length CD40LG constructs and isolated domain variants. Truncated domain fragments cannot support complete surface-partner-complex assembly behaviours, while full-length constructs suit research focused on ligand-subunit-partner interaction and plasma-membrane anchoring functional observation. All batches receive uniform quality screening. Functional-relevant observation may only be carried out with full-length samples under simulated plasma-membrane microenvironment setups. Consistent structural features are preserved across batches to support comparative laboratory analysis across separate test groups. Full-length CD40LG samples retain intact partner-interaction-domain conformation after standardized purification, which supports reliable detection of weak and transient subunit-partner contacts for comparative functional analysis.
Not finding the membrane protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides adjustable CD40LG expression cell research models with varied expression levels, applicable to structural observation of type-II transmembrane TNF-superfamily ligand proteins and research into membrane-partner molecular interaction. Sample evaluation includes sustained target expression detection and preliminary partner-interaction observation, enabling side-by-side comparison of subunit-binding behaviours under differing expression abundances. These cell systems can pair with diverse laboratory analysis schemes to track changes in partner-assembly efficiency alongside shifting target protein levels.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-CD40LG recombinant antibodies are generated via standardized protein preparation workflows, compatible with routine laboratory detection techniques for plasma-membrane localization mapping and identification of subunit-partner molecular complexes. The antibody series can work alongside common laboratory detection reagents to realize multi-dimensional observation of target distribution within membrane-enriched sample materials.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for CD40LG research:
CD40LG might act as a type-II transmembrane TNF-superfamily ligand protein and participate in heteromeric plasma-membrane complex assembly to modulate immune-cell-surface-complex arrangement and plasma-membrane homeostasis.
CD40LG expression status could alter membrane-partner-complex assembly efficiency and local plasma-membrane-coupled molecular-interaction balance, serving as a major ligand mediator of immune-cell-surface-associated biological processes.
No, CD40LG-associated research reagents from Creative Biolabs are exclusively built for exploring membrane-ligand-dependent immune-surface-complex regulatory mechanisms, and shall not be deployed for any clinical-oriented workflows. These preparations are optimized for basic laboratory investigation and do not satisfy performance benchmarks required for clinical implementation.
Offerings include full-length CD40LG membrane protein, target-specific recombinant antibodies and tunable expression cell research models, supporting research on plasma-membrane homeostasis and membrane-ligand-mediated membrane-partner perception.
Laboratory observation schemes may include subunit-partner interaction related tests to analyse molecular-binding associated behaviors under simulated plasma-membrane environments.
